Pietruszewska Wioletta, Bojanowska-Pozniak Katarzyna, Józefowicz-Korczyńska Magdalena, Durko Marcin, Kobos Józef
Katedra i Klinika Otolaryngologii Uniwersytetu Medycznego w Lodzi.
Otolaryngol Pol. 2007;61(4):602-6. doi: 10.1016/S0030-6657(07)70494-8.
The diagnosis and treatment of laryngeal premalignant lesions has been frustrated because of failure to adequately define the histologic changes that may help in prediction of irreversible neoplastic transformation. To assess the grading of laryngeal hyperplastic epithelial lesion it was used a Ljubljana classification of histologic changes. It was done a retrospective study of 104 laryngeal hyperplastic lesions biopsies that were classified according to the Ljubljana classification comprising benign spinous layer augmentation (simple hyperplasia), benign basal and parabasal layer augmentation (abnormal hyperplasia), alteration of epithelial cells towards malignancy (atypical hyperplasia) and carcinoma in situ. One hundred and four biopsies with preneoplastic changes were reevaluated and classified according to Ljubljana classification. It was found 42 cases (40.4%) which showed simple, 38 (36.5%) abnormal, 21 (20.2%) atypical hyperplasia and 3 (2.9%) carcinoma in situ. Three cases of atypical hyperplasia (2.9% of all investigated cases) and one of abnormal (0.96%) progressed to invasive carcinoma during the observation ranging from 5 to 9 years (median 8.1). None of the cases classified as simple hyperplasia showed progression to malignancy. The Ljubljana classification focuses on the important clinical decision involving benign looking hyperplastic lesion that do not require strict follow-up (simple and abnormal hyperplasia); and "risky" epithelium that require close follow-up with repeated histologic assessment to recognize any malignant progression (atypical hyperplasia); and carcinoma in situ that requires fast and complete treatment. We suggest that the Ljubljana classification may give a reliable assessment of laryngeal hyperplastic epithelial lesions and can help in monitoring all those patients.
由于未能充分界定可能有助于预测不可逆性肿瘤转化的组织学变化,喉癌前病变的诊断和治疗一直受到困扰。为了评估喉增生性上皮病变的分级,采用了卢布尔雅那组织学变化分类法。对104例喉增生性病变活检标本进行了回顾性研究,这些标本根据卢布尔雅那分类法进行分类,包括良性棘层增厚(单纯增生)、良性基底和副基底层增厚(异常增生)、上皮细胞向恶性改变(非典型增生)和原位癌。对104例有癌前病变的活检标本重新进行评估,并根据卢布尔雅那分类法进行分类。发现42例(40.4%)表现为单纯增生,38例(36.5%)为异常增生,21例(20.2%)为非典型增生,3例(2.9%)为原位癌。在5至9年(中位值8.1年)的观察期内,3例非典型增生(占所有研究病例的2.9%)和1例异常增生(0.96%)进展为浸润性癌。所有分类为单纯增生的病例均未进展为恶性肿瘤。卢布尔雅那分类法侧重于涉及无需严格随访的良性增生性病变(单纯增生和异常增生)的重要临床决策;以及需要密切随访并反复进行组织学评估以识别任何恶性进展的“危险”上皮(非典型增生);以及需要快速和彻底治疗的原位癌。我们认为,卢布尔雅那分类法可能对喉增生性上皮病变作出可靠评估,并有助于对所有这些患者进行监测。